Sfrowasa
NDC Package 0037-0022-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sfrowasa is mesalamine (also known as 5-aminosalicylic acid) is used to treat certain types of bowel disease (distal ulcerative colitis, proctosigmoiditis, proctitis). Marketed by Viatris Specialty Llc, this product is identified by NDC 0037-0022 and is authorized under FDA application NDA019618.

Identification & Billing

NDC Package Code
0037-0022-28
Package Description
28 BOTTLE, WITH APPLICATOR in 1 CARTON / 60 mL in 1 BOTTLE, WITH APPLICATOR (0037-0022-60)
Product Code
11-Digit Billing Format
00037002228
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Sfrowasa Sulfite-free Formulation
Dosage Form
-
Usage Information
Mesalamine (also known as 5-aminosalicylic acid) is used to treat certain types of bowel disease (distal ulcerative colitis, proctosigmoiditis, proctitis). It does not cure these conditions, but it may relieve mild-to-moderate pain and decrease the frequency of diarrhea/bloody stools caused by irritation/swelling in the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling.

Regulatory & Marketing

Labeler Name
Viatris Specialty Llc
FDA Application #
NDA019618
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-24-2016
End Marketing Date
07-31-2026
Listing Expiration
07-31-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0037-0022). Click a package code to view its specific billing and regulatory data.

7 BOTTLE, WITH APPLICATOR in 1 CARTON / 60 mL in 1 BOTTLE, WITH APPLICATOR (0037-0022-60)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0037-0022-28 identifies a specific commercial package of 28 bottle, with applicator in 1 carton / 60 ml in 1 bottle, with applicator (0037-0022-60) of Sfrowasa Sulfite-free Formulation, labeled by Viatris Specialty Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Viatris Specialty Llc on March 24, 2016. The current certification is valid through July 31, 2026.

What are the primary indications for this medication?

Mesalamine (also known as 5-aminosalicylic acid) is used to treat certain types of bowel disease (distal ulcerative colitis, proctosigmoiditis, proctitis). It does not cure these conditions, but it may relieve mild-to-moderate pain and decrease the frequency of diarrhea/bloody stools caused by irritation/swelling in the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling.

How is this Viatris Specialty Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00037002228. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0037-0022-28
11-Digit CMS (5-4-2)
00037-0022-28

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.